SCN is launching the second of two national research funding competitions and Breakthrough T1D is excited to partner again on joint-funding award opportunities!    Webinar: August 13, 2026, at 1pm ET Competition opens August 31, 2026. More details here: tinyurl.com/SCN-FO

Research Funding - Stem Cell Network

For more than 20 years, the Stem Cell Network has made strategic investments in stem cell and regenerative medicine research, helping to position Canada as a global leader in the field. As Canada’s on...

tinyurl.com

A new step toward cures for type 1 diabetes in Canada. Breakthrough T1D Canada has formally asked the federal government to partner in launching the Breakthrough T1D Network for Canada (BTNC), a national effort to accelerate treatments for #T1D. 💙 Learn more 🔗 ow.ly/yi8850YH60L

Breakthrough T1D Canada is pleased to announce three new trainees joining the fourth cohort of our partnership with the Canadian Islet Research and Training Network @cirtn.bsky.social Learn more about their research and the impact of this collaboration: breakthrought1d.ca/breakthrough...

Calling all residents and fellows interested in type 1 diabetes #T1D research! Breakthrough T1D Canada's Clinician Investigator Fellowship is currently open for applications. Up to $50,000 salary support per year. Deadline to submit is March 31st. breakthrought1d.ca/research/gra...

Mark your calendars for October 9–11, 2026, in Philadelphia, PA, for the first-ever Breakthrough T1D Clinical & Research Congress (CRC)! #CRC2026 Learn more:   bt1dcongress.org

I'm excited to share that we are hiring two positions with Breakthrough T1D (formerly JDRF) Canada! National Specialist, Research & Mental Health (Bilingual) National Manager, Medical Affairs Please pass these along to anyone who may be interested: jobs-ca.silkroad.com/breakthrough...

Thanks to @stemcellnetwork.ca for a fantastic #TMM2025 conference. Highlights: 🎉 Celebrating our partnership with SCN @breakthrought1dca.bsky.social 📝 Learning about regenerative medicine updates in #T1D 💭 Thought-provoking sessions on science funding, policy, and commercialization

Official posting coming soon, but here's a heads-up: #Postdoc Opportunity for individuals with an interest in advancing the understanding of pancreatic islet hormones in health and #diabetes. Diverse backgrounds, skill sets and experiences are welcome! www.bcell.org

Last week, Breakthrough T1D Canada had the privilege of co-hosting a workshop with Canada’s Stem Cell Network and Shift Health focused on a critical and complex topic:  "Unlocking Access for Type 1 Diabetes Cell Therapies in Canada: Identifying Solutions for Regulatory and Reimbursement Success."

‘Official’ results from the Vertex VX-880 trial using stem cell-derived islets for people with type 1 diabetes #T1D 10 out of 12 people with reduced or eliminated need for insulin 🎉 But note the need for immunosuppression and limited eligibility… this is not (YET) the ‘cure for everyone’

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...

nejm.org

Excellent to see this Breakthrough T1D and CIHR-funded research by Dr. Mahmud at SickKids (Toronto) that shows improved glycemic control and kidney function when using the drug dapagliflozin in youth. Exciting to see research progress toward adjunctive therapies for #T1D.

Clinical trial shows improved health outcomes for teens with type 1 diabetes

A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney disease and improve health outcomes. The findings could help guide more prec...

temertymedicine.utoronto.ca

📣 Calling all trainees and early-career researchers studying type 1 diabetes #T1D Breakthrough T1D has postdoctoral fellowships and early careers awards for academics and clinician-scientists. 🗓️ Proposals due July 1 International applicants welcome! www.breakthrought1d.org/explore-rese...

Type 1 Diabetes Funding Opportunities - Breakthrough T1D

Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.

breakthrought1d.org

What a legacy 🇨🇦 Drs. Till & McCulloch discovered stem cells in the 60s which changed the future of regenerative medicine and contributed to solving one of the biggest hurdles (having enough cells) in the quest to cure type 1 diabetes #T1D #stemcell

Stem Cell Network@stemcellnetwork.ca · last yr.

(1/3) It is with profound sadness that we honour the passing of Dr. James Till, a pioneering Canadian scientist whose work, alongside Dr. Ernest McCulloch, laid the very foundation of stem cell research. stemcellnetwork.ca/celebrating-...

A short (12-min) interview about the current and future of islet transplantation. Worth a listen for anyone interested in learning more about cures for #T1D

European Association for the Study of Diabetes@easdnews.bsky.social · last yr.

🎙️The future of #T1D care: Are we closing in on a cell-based cure? From islet transplants to stem cell-derived therapies, experts Dr James Shaw, Dr Timothy Kieffer & Dr Trevor Reichman explore the cutting edge of regenerative diabetes treatment. 🎧Listen now 👉 www.easd.org/media-centre...

Yesterday, Health Canada approved the first disease-modifying therapy for type 1 diabetes #T1D. This is a ‘preventative’ (actually ‘delaying’) therapy that addresses autoimmunity *before* someone is diagnosed and requiring insulin. breakthrought1d.ca/news/health-...

Health Canada approves Tzield – the first ever disease modifying therapy for type 1 diabetes | Breakthrough T1D

On May 5, 2025, Sanofi announced Health Canada approval of Tzield, the first disease-modifying therapy for type 1 diabetes (T1D). This is a huge win for the T1D community in that it is the first medic...

breakthrought1d.ca

Several BreakthroughT1D funding opportunities available 1) Advancing GRS, especially in non-European backgrounds 2) Early detection in adult-onset T1D 3) Tech for scaling manufactured islets Feel free to reach out with questions. Open to industry and academia #funding #grants #T1D

Type 1 Diabetes Funding Opportunities - Breakthrough T1D

Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.

breakthrought1d.org

Beyond the Numbers: Real Stories of Navigating Mental Health with type 1 diabetes #T1D. This powerful new video series shares the honest, emotional stories of adults living with type 1 diabetes. 💙 🔗 Watch the series ow.ly/aqb950VKwkL 🔗 Explore mental health & T1D resources ow.ly/J49v50VKwkK

Beyond the Numbers: Real Stories of Navigating Mental Health with T1D | Au-delà des chiffres : De vraies histoires sur la santé mentale avec le DT1 - YouTube

ow.ly

Great new research - one of the difficult aspects of #T1D is that there’s no way to “see” islet or beta cells to check if they are being attacked or functioning well so new biomarkers are important! (More info in comments…)

STOP T1D@stopt1d.bsky.social · last yr.

#T1D Research Report Findings: "M120 identified 26% more children at high risk of progression" of #Type1Diabetes. "M120 Risk Score Improves Identification of Children at High Risk of Developing Clinical Type 1 Diabetes and Reports Short-Term Response to Preventive Immunotherapy" bit.ly/4jwYfGL

So much knowledge comes from a registry - this is a catalyst for many other research projects and often helps guide research priorities! If you (or your child) lives with type 1 diabetes #T1D #LADA and are located in Canada 🇨🇦, PLEASE consider contributing to research! (Completely virtual too).

Type 1 BETTER@type1better.bsky.social · last yr.

🎉 5,000 people have joined the BETTER registry! 🎉 Thanks to you, research is moving forward and we’re improving our understanding of the realities faced by people living with type 1 diabetes and LADA in Canada. #type1diabetes #BETTERregistry #diabetesresearch #T1D #LADA #Canada #PatientVoices

Adult living with #T1D in Edmonton, #Canada…? Consider participating in clinical trials to explore new therapies. Not in Edmonton - look for other actively recruiting trials for type 1 diabetes here clinicaltrials.breakthrought1d.ca/search

Dr Peter Senior@islettx.bsky.social · last yr.

www.nature.com/naturecareer... UBC LSI Job!!

Assistant Professor (tenure track) – Chromatin, Epigenetics - Vancouver, British Columbia (CA) job with The University of British Columbia (UBC) | 12837841

Assistant Professor (tenure track) - Chromatin Regulation, Genetic Regulatory Mechanisms, Epigenetics, Epigenomics

nature.com

VERY important research from the fantastic Dr. Jane Speight. The burden of self-managed chronic conditions should not be underestimated! If you live in Canada and want to find a mental health worker that understands diabetes burden ( #T1D or #T2D) - check on our directory.breakthrought1d.ca

European Association for the Study of Diabetes@easdnews.bsky.social · last yr.

❓What is the psychosocial impact of living with #diabetes? 🔎In our new Gamechangers episode, Prof. Jane Speight spotlights a paper that, for the first time, outlined the concept of #diabetesdistress. 📺Watch here: easd-elearning.eu/index.html@p... #elearning

Unfortunate to see today’s news from Vertex about their VX-264 therapy for #T1D but this is why we always have ‘multiple shots on goal’! Considering that the same cells are being used as in VX-880 (so far great data) it’s reasonable to assume that the device encapsulation was the problem here.

Always exciting to see new Clinical Practice Guidelines, but these are especially exciting: - T1D across the lifetime instead of broken up into stages 👏 - recommending AID for all ages and stages of T1D 👏👏 - first in the world to recommend considering the use of adjunctive therapies for T1D 👏👏👏

Really fascinating debate at #ATTD2025 about whether or not we should use placebos in trial design for preventative therapies of #T1D now that Tzield (teplizumab) has shown efficacy and is approved in a few countries. Heavy hitters Colin Dayan and Laura Jacobsen presented excellent points!

This is so powerful… “Has your diabetes been impacted by menopause?” 88% say YES! Research is starting to grow in this area: to see Canadian trials related to menopause and #T1D check out our Clinical Trial Finder clinicaltrials.breakthrought1d.ca

Dawnie@moodwife.bsky.social · last yr.

The #T1D and #Menopause poster has gone live at #ATTD2025 🥳 Thanks to #dedoc° for making it possible for so many of us who were involved to attend

Thrilled to (virtually) watch a fantastic talk at #ATTD2025 from Dr. Cristina Nostro about co-culturing pluripotent stem cells with macrophages which not only provides protection but also increases endocrine output!

www.linkedin.com/posts/emily-... Great post for a very insightful study. IA-2A positive individuals will need close monitoring for #T1D progression!

Emily Sims on LinkedIn: What's up with IA2A?! Excited to share this collaborative work in…

What's up with IA2A?! Excited to share this collaborative work in Diabetologia showing that IA-2A+ is consistently linked to increased disease progression…

linkedin.com

📣Students and postdocs, consider Canadian universities for grad studies! Tuition is typically offset by teaching assistantships for seminars/labs, and applying is as simple as making contact with a PI to start. If you’re in the field of #T1D - reach out if you’d like us to help make a connection!

Francis Lynn 🇨🇦@nictitate.bsky.social · last yr.

It’s pretty easy to “apply” for a PhD in Canada, and a little different from most US places, just send a cover letter, CV and undergrad transcript to a PI you’d like to work with. Put some effort into it, make sure you convey what you’re applying for and why.

Registries are such a critical accelerator for research! If you or someone you know in Canada lives with #T1D, please consider being a part of the BETTER Registry!

Type 1 BETTER@type1better.bsky.social · last yr.

🔬 A study is currently underway using data from the BETTER registry to explore other autoimmune diseases in type 1 diabetes and the associated risks. 💙 Join the registry now if you (or your child) live with type 1 diabetes or LADA in Canada 🇨🇦 🔗 type1better.com/en/the-bette... #T1D #research